Article
Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2012
Xu Jia-Li, Hu Ling-Min, Huang Ming-De, Zhao Wan, Yin Yong-Mei, Hu Zhi-Bin, Ma Hong-Xia, Shen Hong-Bing, Shu Yong-Qian
Abstract excerpt
OBJECTIVE: NBS1 plays a key role in the repair of DNA double-strand break (DSB). We conducted this study to investigate the effect of two critical polymorphisms (rs1805794 and rs13312840) in NBS1 on treatment response and prognosis of advanced non-small cell lung cancer (NSCLC) patients with platinum-based chemotherapy. METHODS: Using TaqMan methods, we genotyped the two polymorphisms in 147 NSCLC patients. Odds...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
